Submissions from 2023
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203, A. Konski, S. Deshmukh, S.L. Pugh, A.H. Klopp, S.N. Westin, A.R. Yeung, J.S. Thompson, D.E. Doncals, G.H.C. Cantuaria, D.P. D'Souza, A. Chang, V. Kundapur, D.S. Mohan, Michael L Haas, Y.B. Kim, C.L. Ferguson, L.A. Kachnic, and D.W. Bruner(Article)
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Patient Reported Outcome Study of NRG Oncology's RTOG 1203, A. Konski, S. Deshmukh, S.L. Pugh, A.H. Klopp, S.N. Westin, A.R. Yeung, J.S. Thompson, D.E. Doncals, G.H.C. Cantuaria, D.P. D'Souza, A. Chang, V. Kundapur, D.S. Mohan, Michael L Haas, Y.B. Kim, C.L. Ferguson, L.A. Kachnic, D.W. Bruner, and A. Konski(Article)
Submissions from 2022
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments., Michael D Chuong, Mary Ann Clark, Lauren E Henke, Amar U Kishan, Lorraine Portelance, Parag J Parikh, Michael F Bassetti, Himanshu Nagar, Stephen A Rosenberg, Minesh P Mehta, Tamer Refaat, Justin M Rineer, Adam Smith, Steven Seung, Bassem I Zaki, Martin Fuss, and Raymond H Mak(Article)